reviewTop 1% cited
Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression
Urology · 2004 · Vol. 63(4) · pp. 682–686
Andreas Böhle✉(Helios Hospital Schwerin)P.R. Bock(Institute for Medical Informatics and Biostatistics)
Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and TreatmentsMedicineOdds ratioInternal medicineConfoundingMitomycin CBladder cancerTumor progressionConfidence intervalRegimenCarcinoma in situ
MeSH terms
Adjuvants, ImmunologicAdministration, IntravesicalAntibiotics, AntineoplasticBCG VaccineUrinary Bladder NeoplasmsCarcinoma, PapillaryCarcinoma, Transitional CellDrug Administration ScheduleFollow-Up StudiesHumansNeoplasm StagingRandomized Controlled Trials as TopicMitomycinTreatment OutcomeDisease Progression
Citations
458
FWCI
12.93
field-weighted impact
References
26
Percentile
99%
vs. same field & year
Citations per year
Cited by
Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update
The Journal of Urology · 2007 · 837 citations
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
European Urology · 2021 · 1,541 citations
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
European Urology · 2019 · 1,294 citations
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
European Urology · 2013 · 1,170 citations
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
European Urology · 2008 · 745 citations
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
European Urology · 2009 · 650 citations
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
European Urology · 2009 · 749 citations
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
European Urology · 2011 · 1,069 citations
References
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
The Journal of Urology · 2002 · 1,296 citations
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
JNCI Journal of the National Cancer Institute · 1959 · 14,848 citations
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
The Journal of Urology · 2000 · 1,298 citations
Superficial Bladder Cancer: Progression and Recurrence
The Journal of Urology · 1983 · 945 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.